Along with IL-23, IL-17 levels were significantly increased in the serum and CSF samples of ALS patients, however the levels of the cytokines did correlate with the disease duration, disability scale or the subtype of the disease (Rentzos et al., 2010). This evidence concerns the gene IL17A and amyotrophic lateral sclerosis.